Rasi Electrodes Intrinsic Value
Rasi Electrodes (RASIELEC) median intrinsic value is ₹24.92 from 9 valuation models (range ₹9–₹37), vs current price ₹12.46 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Analyse RASIELEC FII DII holdings to track promoter, FII and institutional holdings.
RASIELEC Valuation Methods Summary — DCF, Graham Number & P/E
Rasi Electrodes intrinsic value across 9 models vs current price ₹12.46 — upside/downside and value range per method. For current market price and key ratios, visit Rasi Electrodes share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹13.80 | ₹11.04 - ₹16.56 | +10.8% | EPS: ₹1.15, Sector P/E: 12x |
| Book Value Method | asset | ₹31.15 | ₹28.04 - ₹34.27 | +150.0% | Book Value/Share: ₹65.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹24.92 | ₹22.43 - ₹27.41 | +100.0% | Revenue/Share: ₹120.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹24.92 | ₹22.43 - ₹27.41 | +100.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹31.15 | ₹24.92 - ₹37.38 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹14.94 | ₹13.45 - ₹16.43 | +19.9% | EPS Growth: 16.2%, Fair P/E: 13.0x |
| Growth Adjusted P/E | growth | ₹9.23 | ₹8.31 - ₹10.15 | -25.9% | Revenue Growth: 0.7%, Adj P/E: 8.0x |
| ROE Based Valuation | profitability | ₹24.92 | ₹22.43 - ₹27.41 | +100.0% | ROE: 10.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹37.38 | ₹33.64 - ₹41.12 | +200.0% | EPS: ₹1.15, BVPS: ₹65.00 |
RASIELEC Intrinsic Value vs Market Price — All Valuation Models
Rasi Electrodes fair value range ₹9–₹37 vs current market price ₹12.46 across 9 valuation models. Read RASIELEC dividend payout details for the complete payout history and dividend yield track record.
RASIELEC Intrinsic Value Analysis — Undervalued or Overvalued?
Rasi Electrodes median intrinsic value ₹24.92, current price ₹12.46 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of RASIELEC?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Rasi Electrodes (RASIELEC) is ₹24.92 (median value). With the current market price of ₹12.46, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹9.23 to ₹37.38, indicating ₹9.23 - ₹37.38.
Is RASIELEC undervalued or overvalued?
Based on our multi-method analysis, Rasi Electrodes (RASIELEC) appears to be trading below calculated value by approximately 100.0%.
RASIELEC Financial Health — Key Ratios vs Industry Benchmarks
Rasi Electrodes financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 35.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 10.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.76x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
RASIELEC Cash Flow Quality — Operating & Free Cash Flow
Rasi Electrodes operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹8 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |